The Lancet Neurology in conversation with
The Lancet Neurology in conversation with
The Lancet Group
Eva Feldman on advances in understanding ALS
22 minutes Posted Apr 13, 2022 at 10:00 pm.
0:00
22:43
Download MP3
Show notes

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.